Carole S. Ben-Maimon
Overview
Carole S. Ben-Maimon received an average of $3M in total compensation, including $435K in salary, at Zafgen from 2020 to 2022. Carole Ben-Maimon also received an average of $2M at Impax Laboratories from 2011 to 2014.
- 2022
- 2021
- 2020
- 2014
- 2013
- 2012
- 2011
ZafgenPresident and Chief Executive Officer
ZafgenPresident and Chief Executive Officer
ZafgenPresident and Chief Executive Officer
Impax LaboratoriesFormer President, Impax Generics Division
Impax LaboratoriesFormer President, Impax Generics Division
Impax LaboratoriesFormer President, Impax Generics Division
Impax LaboratoriesPresident, Global Pharmaceuticals division
Source: SEC filings on April 11, 2023, April 12, 2022, April 14, 2015, and April 15, 2014.
Related executives
We found 14 more executives who work or worked at Zafgen and Impax Laboratories.
Michael Celano
Zafgen
Chief Financial Officer
Jeffrey Hatfield
Zafgen
Chief Executive Officer
Thomas Hughes
Zafgen
Chief Scientific Officer
Brian McVeigh
Zafgen
Chief Business Officer
Dennis Kim
Zafgen
Chief Medical Officer
Patricia Allen
Zafgen
Chief Financial Officer
Alicia Secor
Zafgen
Chief Commercial Officer
G Wilkinson
Impax Laboratories